The companies will produce a domestically manufactured alternative to the immune-regulating cytokine IL-2 in T-cell therapy. Credit: Anusorn Nakdee/Shutterstock.com. Clinical-stage cell therapy company Shanghai Grit
Akantior’s commercialisation rights were acquired by Netherlands-based Avanzanite in January this year. Image credit: Shutterstock / Kateryna Kon. The European Medicines Agency’s (EMA) Committee for
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been selected for Innovate UK’s Global Incubator
Mirum is seeking to expand its label for younger PFIC patients in 2024 in the US. Credit: Kmpzzz/Shutterstock.com. The European Medicines Agency’s Committee for Medicinal
The therapeutic role of recombinant banana lectin (rBanLec) concerning IBD control and raising vaccination rates.
DefiniGEN Ltd., and Atelerix Ltd., today announced they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US.
Credit: Shutterstock Drug shortages worldwide are worsening due to increased demand for high-quality manufacturing capacity in the pharmaceutical industry. Short-term contingency plans from healthcare providers
The effects of statins via inhibition of interleukin 33 (IL-33).
Whether sodium-glucose co-transporter 2 (SGLT2) inhibitors induce senolysis.
The association between vegetable and fruit consumption and the risk of sarcopenia.